Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex

EMBO Reports

Volumn 8, Issue 9, 2007, Pages 879-884

  Vannini, Alessandro ^a   Volpari, Cinzia ^a   Gallinari, Paola ^a   Jones, Philip ^a   Mattu, Marco ^a   Carfí, Andrea ^a   De Francesco, Raffaele ^a   Steinkühler, Christian ^a   Di Marco, Stefania ^a  

^a IRBM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARTIC ACID; HISTONE DEACETYLASE 8; HISTONE DEACETYLASE INHIBITOR; PHENYLALANINE; TYROSINE;

ARTICLE; BINDING ASSAY; CONTROLLED STUDY; CRYSTAL STRUCTURE; DEACETYLATION; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME INHIBITOR INTERACTION; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STRUCTURE ANALYSIS; WILD TYPE;

EID: 35548947488     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7401047     Document Type: Article

References (26)

1. Blander G, Guarente L (2004) The Sir2 family of protein deacetylases. Annu Rev Biochem 73: 417-435
2. Di Gennaro E, Bruzzese F, Caraglia M, Abruzzese A, Budillon A (2004) Acetylation of proteins as novel target for antitumor therapy: Review article. Amino Acids 26: 435-441
3. Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, Breslow R, Pavletich NP (1999) Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401: 188-193
4. Fischle W, Dequiedt F, Hendzel MJ, Guenther MG, Lazar MA, Voelter W, Verdin E (2002) Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell 9: 45-57
5. Gallinari P, Di Marco S, Jones P, Pallaoro M, Steinkühler C (2007) HDACs, histone deacetylation and gene transcription: From molecular biology to cancer therapeutics. Cell Res 17: 195-211
6. Gregoretti IV, Lee YM, Goodson HV (2004) Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis. J Mol Biol 338: 17-31
7. Hassig CA, Tong JK, Fleischer TC, Owa T, Grable PG, Ayer DE, Schreiber SL (1998) A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc Natl Acad Sci USA 95: 3519-3524
8. Holbert MA, Marmorstein R (2005) Structure and activity of enzymes that remove histone modifications. Curr Opin Struct Biol 15: 673-680
9. Jones P et al (2006) A series of novel, patent, and selective histone deacetylase inhibitors. Bioorg Med Chem Lett 16: 5948-5952
10. Kapustin GV, Fejer G, Gronlund JL, McCafferty DG, Seto E, Etzkom FA (2003) Phosphorus-based SAHA analogues as histone deacetylase inhibitors. Org Lett 5: 3053-3056
11. Laskowski RA (2003) Structural quality assurance. Methods Biochem Anal 44: 273-303
12. Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD, Berger SL (1999) p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 19: 1202-1209
13. Marks PA, Miller T, Richon VM (2003) Histone deacetylases. Curr Opin Pharmacol 3: 344-351
14. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D 53: 240-255
15. Navaza J (2001) Implementation of molecular replacement in AMoRe. Acta Crystallogr D 57: 1367-1372
16. Nielsen TK, Hildmann C, Dickmanns A, Schwienhorst A, Ficner R (2005) Crystal structure of a bacterial class 2 histone deacetylase homologue. J Mol Biol 354: 107-120
17. Rodriquez M, Aquino M, Bruno I, De Martino G, Taddei M, Gomez-Paloma L (2006) Chemistry and biology of chromatin remodeling agents: State of art and future perspectives of HDAC inhibitors. Curr Med Chem 13: 1119-1139
18. Roth SY, Denu JM, Allis DC (2001) Histone acetyltransferases. Annu Rev Biochem 70: 81-120
19. Schuttelkopf AW, van Aalten DM (2004) PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D 60: 1355-1363
20. Sengupta N, Seto E (2004) Regulation of histone deacetylase activities. J Cell Biochem 93: 57-67
21. Somoza JR et al (2004) Structural snapshots of human HDAC8 provide insights into the class I histone cleacetylases. Structure 12 1325-1334
22. Vaghefi H, Neet KE (2004) Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation. Oncogene 23: 8078-8087
23. Vannini A et al (2004) Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. Proc Natl Acad Sci USA 101: 15064-15069
24. Vanommeslaeghe K, Van Alsenoy C, De Proft F, Martins JC, Tourwe D, Geerlings P (2003) Ab initio study of the binding of trichostatin A (TSA) in the active site of histone deacetylase like protein (HDLP). Org Biomol Chem 1: 2951-2957
25. Vanommeslaeghe K, De Proft F, Loverix S, Tourwe D, Geerlings P (2005) Theoretical study revealing the functioning of a novel combination of catalytic motifs in histone deacetylase. Bioorg Med Chem 13: 3987-3992
26. Yang XJ, Seto E (2003) Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression. Curr Opin Genet Dev 13: 143-153